Clinical Trial Update: Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing AzaSite Plus vs AzaSite alone and dexamethasone alone for blepharoconjunctivitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharoconjunctivitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)
• AzaSite Plus
• Dexamethone/Dexamethasone (dexamethasone)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Blepharoconjunctivitis | Phase 3 | Status: WITHDRAWN